Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA.
Level 5 - mechanism / opinion, no new human data
Bench/laboratory in vitro study without clinical human trial data.
PubMed 16111635 · doi:10.1016/j.immuni.2005.06.008
What was done
Investigators evaluated the innate immune response to RNA containing modified nucleosides (m5C, m6A, m5U, s2U, or pseudouridine) versus unmodified RNA in human TLR3-, TLR7-, and TLR8-expressing cells and dendritic cells (DCs). They also compared dendritic cell activation following exposure to bacterial RNA, mitochondrial RNA, and mammalian total RNA.
What was found
Unmodified RNA activated human TLR3, TLR7, and TLR8, whereas incorporation of modified nucleosides ablated this signaling. Dendritic cells exposed to modified RNA expressed significantly less cytokines and activation markers compared to those exposed to unmodified RNA. Bacterial and mitochondrial RNA potently activated DCs and TLR-expressing cells, while mammalian total RNA did not. The abstract reports no numerical values or statistical metrics.
Why it matters
This paper identifies that nucleoside modifications prevent RNA from activating Toll-like receptors and triggering dendritic cell responses, establishing the foundation for designing non-immunogenic mRNA.
Limits
The study is restricted to in vitro bench assays and cell cultures, without in vivo animal or clinical human trial data. The abstract provides no quantitative effect sizes, variance estimates, or sample sizes.
Cited by
- supports In 2005, researchers figured out how to modify nucleotides in mRNA molecules to prevent early destruction and allow them to last long enough to make protein.